Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 6/20 | 0.40 |
| ▸ | GRM5 | P41594 | 3/20 | 0.36 |
| ▸ | GRM1 | Q13255 | 3/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GBA1 | P04062 | 1/20 | 0.34 |
| ▸ | BUB1 | O43683 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7528678 | 0.88 | ESR2 (0.40) | GPR119BCHEBUB1ESR2 | |
| SCHEMBL19638080 | 0.72 | GPR119 (0.38) | GPR119GRM5GRM1BCHEBUB1 | |
| SCHEMBL28282013 | 0.72 | GPR119 (0.39) | GPR119BCHEGBA1 | |
| SCHEMBL11911366 | 0.72 | GPR119 (0.39) | GPR119GRM5GRM1BCHEBUB1 | |
| SCHEMBL12593934 | 0.70 | NR1H2 (0.41) | GPR119BCHEBUB1ESR2 | |
| SCHEMBL20033881 | 0.70 | BCHE (0.38) | GPR119BCHEBUB1ESR2 | |
| SCHEMBL28581988 | 0.70 | BCHE (0.38) | GPR119GRM5GRM1BCHEBUB1 | |
| SCHEMBL1018306 | 0.70 | BCHE (0.38) | GPR119BCHEBUB1ESR2 | |
| SCHEMBL15687908 | 0.70 | POLB (0.38) | GPR119BCHEPOLB | |
| SCHEMBL21190321 | 0.69 | BCHE (0.44) | GPR119BCHEBUB1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110177786-A | Pyrazolo [1,5-A] pyridine compounds being substituted are as RET kinase inhibitor | 阿雷生物药品公司 | 2019-08-27 | — | — | CN | disclosed |